Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
Bertram Pitt(Bayer (Germany)), Balasamy Thiyagarajan(United States Military Academy), George Klinger(United States Military Academy), Marvin A. Konstam(Tufts Medical Center), Felipe A Martinez(Instituto Médico DAMIC), Philip A. Poole‐Wilson(The Royal Free Hospital), James D. Neaton(University of Minnesota System), Kenneth Dickstein, Robert Segal(United States Military Academy), A. John Camm(St George's, University of London), Günter A.J. Riegger(University Hospital Regensburg), Divakar Sharma(United States Military Academy)
Cited by 1,960
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k